Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment
Launched by KAISER PERMANENTE · Mar 12, 2024
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Systematic Implementation of Patient-centered Care for Alcohol Use Trial is a research study aimed at improving how we help people with alcohol use problems. This trial will test two new approaches to care in about 25 primary care clinics. The goal is to better support patients by involving them in decisions about their treatment, making it more personalized to their needs. Participants will be divided into groups to receive either the usual care they typically get, one of the new care approaches, or another centralized support option.
To join the study, you need to be an adult aged 18 or older and have certain symptoms related to alcohol use, as measured by a checklist. Specifically, you should have at least four symptoms or two to three symptoms along with a high-risk drinking score. Importantly, this trial is not yet recruiting participants, but it will include all genders. If you decide to take part, you can expect to receive support tailored to your situation to help you manage your alcohol use effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult primary care patients ≥18 years old on the day of a primary care appointment; and
- • 2. ≥4 symptoms on the Alcohol Symptom Checklist, or 2-3 symptoms on the Alcohol Symptom Checklist with at least one symptom associated with high risk of progression to severe symptoms, documented in the electronic health record associated with the primary care appointment; and
- • 3. high-risk drinking on the alcohol screening questionnaire (AUDIT-C ≥7) on the day of the Alcohol Symptom Checklist or in the prior 30 days documented in the electronic health record.
- Exclusion Criteria:
- • 1. Documented request to not participate in research, or
- • 2. Patient was eligible for the Vanguard pilot study.
About Kaiser Permanente
Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Seattle, Washington, United States
Patients applied
Trial Officials
Katharine Bradley, MD, MPH
Principal Investigator
Kaiser Permanente
Gwen Lapham, PhD, MPH, MSW
Principal Investigator
Kaiser Permanente
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported